Search research articles
Contact Us
Filters
Showing results (111-120 of 277) with videos related to
Page
of 28
Sort By:
American Journal of Public Health
|
June 29, 2022
Scaling Up Evidence-Based Practices in Contraceptive Access Initiatives
Nikita M Malcolm, Katrin V Patterson, Ellen S Pliska, et al.
Chemmedchem
|
January 3, 2019
TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure
Maria Kalyukina, Yuliana Yosaatmadja, Martin J Middleditch, et al.
Current Pharmaceutical Design
|
June 8, 2002
Antiangiogenic, bioreductive and gene therapy approaches to the treatment of hypoxic tumours
Virginia A McNally, Adam V Patterson, Kaye J Williams, et al.
Biochemical Pharmacology
|
October 24, 2018
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy
Jasmine V E Chan-Hyams, Janine N Copp, Jeff B Smaill, et al.
Cancer Research
|
October 3, 2008
Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104
Shie-Chau Liu, G-One Ahn, Mitomu Kioi, et al.
Biochemical Pharmacology
|
July 25, 2007
Identification of human reductases that activate the dinitrobenzamide mustard prodrug PR-104A: a role for NADPH:cytochrome P450 oxidoreductase under hypoxia
Chris P Guise, Anderson T Wang, Anke Theil, et al.
BMC Cardiovascular Disorders
|
June 14, 2017
Unlocking echocardiogram measurements for heart disease research through natural language processing
Olga V Patterson, Matthew S Freiberg, Melissa Skanderson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 4, 2019
Atropselective Oxidation of 2,2',3,3',4,6'-Hexachlorobiphenyl (PCB 132) to Hydroxylated Metabolites by Human Liver Microsomes and Its Implications for PCB 132 Neurotoxicity
Eric Uwimana, Brianna Cagle, Coby Yeung, et al.
Journal of the American Chemical Society
|
February 10, 2010
Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine)
Sujata S Shinde, Andrej Maroz, Michael P Hay, et al.
Psychiatry Research
|
May 5, 1997
Effects of P50 temporal variability on sensory gating in schizophrenia
Y Jin, S G Potkin, J V Patterson, et al.
Page
of 28
Search research articles
Search
Showing results (111-120 of 277) with videos related to
Sort By:
Page
of 28
American Journal of Public Health
|
June 29, 2022
Scaling Up Evidence-Based Practices in Contraceptive Access Initiatives
Nikita M Malcolm, Katrin V Patterson, Ellen S Pliska, et al.
Chemmedchem
|
January 3, 2019
TAS-120 Cancer Target Binding: Defining Reactivity and Revealing the First Fibroblast Growth Factor Receptor 1 (FGFR1) Irreversible Structure
Maria Kalyukina, Yuliana Yosaatmadja, Martin J Middleditch, et al.
Current Pharmaceutical Design
|
June 8, 2002
Antiangiogenic, bioreductive and gene therapy approaches to the treatment of hypoxic tumours
Virginia A McNally, Adam V Patterson, Kaye J Williams, et al.
Biochemical Pharmacology
|
October 24, 2018
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy
Jasmine V E Chan-Hyams, Janine N Copp, Jeff B Smaill, et al.
Cancer Research
|
October 3, 2008
Optimized clostridium-directed enzyme prodrug therapy improves the antitumor activity of the novel DNA cross-linking agent PR-104
Shie-Chau Liu, G-One Ahn, Mitomu Kioi, et al.
Biochemical Pharmacology
|
July 25, 2007
Identification of human reductases that activate the dinitrobenzamide mustard prodrug PR-104A: a role for NADPH:cytochrome P450 oxidoreductase under hypoxia
Chris P Guise, Anderson T Wang, Anke Theil, et al.
BMC Cardiovascular Disorders
|
June 14, 2017
Unlocking echocardiogram measurements for heart disease research through natural language processing
Olga V Patterson, Matthew S Freiberg, Melissa Skanderson, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
July 4, 2019
Atropselective Oxidation of 2,2',3,3',4,6'-Hexachlorobiphenyl (PCB 132) to Hydroxylated Metabolites by Human Liver Microsomes and Its Implications for PCB 132 Neurotoxicity
Eric Uwimana, Brianna Cagle, Coby Yeung, et al.
Journal of the American Chemical Society
|
February 10, 2010
Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine)
Sujata S Shinde, Andrej Maroz, Michael P Hay, et al.
Psychiatry Research
|
May 5, 1997
Effects of P50 temporal variability on sensory gating in schizophrenia
Y Jin, S G Potkin, J V Patterson, et al.
Page
of 28